Literature DB >> 15705403

Abnormal aminotransferase activity in women with polycystic ovary syndrome.

Jeffrey B Schwimmer1, Omid Khorram, Vicki Chiu, Walter B Schwimmer.   

Abstract

Alanine aminotransferase (ALT) activity was abnormal in 30% of 70 female infertility patients with polycystic ovary syndrome in whom causes other than nonalcoholic fatty liver disease were excluded by history and serum testing. Women with elevated ALT had significantly higher body mass index, waist circumference, serum triglycerides, total cholesterol-to-HDL-cholesterol ratio, and degree of insulin resistance.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15705403     DOI： 10.1016/j.fertnstert.2004.08.020

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  18 in total

Review 1.  Nonalcoholic fatty liver disease and polycystic ovary syndrome.

Authors:  Evangeline Vassilatou
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 2.  Targets to treat metabolic syndrome in polycystic ovary syndrome.

Authors:  Shruthi Mahalingaiah; Evanthia Diamanti-Kandarakis
Journal:  Expert Opin Ther Targets       Date:  2015-10-21       Impact factor: 6.902

Review 3.  Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

Authors:  Stavroula A Paschou; Stergios A Polyzos; Panagiotis Anagnostis; Dimitrios G Goulis; Christina Kanaka-Gantenbein; Irene Lambrinoudaki; Neoklis A Georgopoulos; Andromachi Vryonidou
Journal:  Endocrine       Date:  2019-09-19       Impact factor: 3.633

4.  High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance.

Authors:  J Cai; C H Wu; Y Zhang; Y Y Wang; W D Xu; T C Lin; S X Li; L H Wang; J Zheng; Y Sun; W Liu; T Tao
Journal:  Int J Obes (Lond)       Date:  2017-05-10       Impact factor: 5.095

Review 5.  Cardiometabolic aspects of the polycystic ovary syndrome.

Authors:  Harpal S Randeva; Bee K Tan; Martin O Weickert; Konstantinos Lois; John E Nestler; Naveed Sattar; Hendrik Lehnert
Journal:  Endocr Rev       Date:  2012-07-24       Impact factor: 19.871

Review 6.  Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

Authors:  Carly E Kelley; Ann J Brown; Anna Mae Diehl; Tracy L Setji
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 7.  Endocrine and liver interaction: the role of endocrine pathways in NASH.

Authors:  Paola Loria; Lucia Carulli; Marco Bertolotti; Amedeo Lonardo
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-04       Impact factor: 46.802

8.  Upper Normal Alanine Aminotransferase Range and Insulin Resistance in Korean Adolescents: Korean National Health and Nutrition Examination Survey, 2009-2010.

Authors:  Yoon Lee; Kyung-Do Han; Jennifer Jaeeun Jung; Kee-Hyoung Lee; Kyung-Hwan Cho; Yang-Hyun Kim
Journal:  Dig Dis Sci       Date:  2015-12-24       Impact factor: 3.199

9.  Polycystic ovary syndrome and nonalcoholic fatty liver in obese adolescents: association with metabolic risk profile.

Authors:  Sara F Michaliszyn; Sojung Lee; Hala Tfayli; Silva Arslanian
Journal:  Fertil Steril       Date:  2013-09-11       Impact factor: 7.329

10.  Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome.

Authors:  G Targher; E Solagna; F Tosi; R Castello; G Spiazzi; G Zoppini; M Muggeo; C P Day; P Moghetti
Journal:  J Endocrinol Invest       Date:  2009-06-18       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.